drugset
drugset / Trial / NCT00818194

Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers

NCT00818194 ↗

Phase 1 Completed 18 enrolled Astellas Pharma Inc Astellas Pharma Canada, Inc. · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the effects of steady state tacrolimus vs. cyclosporine on renal pharmacodynamics in healthy volunteers.

Timeline

Start
2008-04
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide — Oral
Subject Tacrolimus Small molecule — Oral

Indications

No indication recorded.